Alex Tarrabain is Chief Financial Officer of CEN BIOTECH INC. Currently has a direct ownership of 2.78 Million shares of CENBF, which is worth approximately $0. The most recent transaction as insider was on Jun 25, 2021, when has been sold 1,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.78M
0% 3M change
0% 12M change
Total Value Held $0

Alex Tarrabain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2021
BUY
Grant, award, or other acquisition
-
1,000,000 Added 26.48%
2,775,942 Common Stock
Jun 16 2021
BUY
Other acquisition or disposition
-
3,000 Added 0.11%
2,775,942 Common Stock
May 16 2021
BUY
Other acquisition or disposition
-
3,000 Added 0.17%
1,772,942 Common Stock
Apr 16 2021
BUY
Other acquisition or disposition
-
3,000 Added 0.17%
1,772,942 Common Stock
Apr 10 2021
BUY
Conversion of derivative security
$48,000 $1.6 p/Share
30,000 Added 1.66%
1,772,942 Common Stock
Apr 02 2021
BUY
Grant, award, or other acquisition
-
300,000 Added 14.47%
1,772,942 Common Stock
Mar 16 2021
BUY
Other acquisition or disposition
-
3,000 Added 0.17%
1,772,942 Common Stock
Feb 16 2021
BUY
Other acquisition or disposition
-
3,000 Added 0.17%
1,772,942 Common Stock
Jan 16 2021
BUY
Other acquisition or disposition
-
3,000 Added 0.17%
1,772,942 Common Stock
AT

Alex Tarrabain

Chief Financial Officer
Windsor, Ontario, Canada, A6

Track Institutional and Insider Activities on CENBF

Follow CEN BIOTECH INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CENBF shares.

Notify only if

Insider Trading

Get notified when an Cen Biotech Inc insider buys or sells CENBF shares.

Notify only if

News

Receive news related to CEN BIOTECH INC

Track Activities on CENBF